Next dispatch cutoff Friday--:--:--

Reference

Laboratory analysis and QC glossary for research peptides

Published 2026-10-29 · updated 2026-10-29 · vendor-authored explanatory note

Short answer

This glossary defines the terms that appear on certificates of analysis and lot reports for research peptides, from the methods (HPLC, LC-MS, LAL) to the results (area percent, identity, net peptide content) and the handling vocabulary (lyophilization, hygroscopic, USP storage temperatures). Each definition links to the primary source it is based on.

Analytical methods

High-performance liquid chromatography (HPLC)
A separation technique that pumps a dissolved sample through a packed column so components elute at different times. For peptides it is the standard way to report chromatographic purity; it separates components but does not by itself prove which molecule a peak is. Source: USP Pharmacopeial Discussion Group · HPLC purity and area percent
Reversed-phase HPLC (RP-HPLC)
The HPLC mode most used to purify and analyze peptides, separating them by hydrophobicity on a non-polar stationary phase. Trifluoroacetic acid is commonly used in the mobile phase, which is why HPLC-purified peptides are often isolated as TFA salts (Cornish et al., 1999). Source: Cornish J et al. Trifluoroacetate
Liquid chromatography-mass spectrometry (LC-MS)
HPLC coupled to a mass spectrometer. The chromatography separates components and the mass spectrometer measures their mass-to-charge ratio, which is how a lot report confirms identity (the observed mass matches the expected molecular weight). Source: ICH Q6B · HPLC vs LC-MS
MALDI-TOF mass spectrometry (MALDI-TOF)
Matrix-assisted laser desorption/ionization with a time-of-flight analyzer. An alternative identity method to LC-MS that measures intact molecular mass without a chromatographic separation step. Source: ICH Q6B
Mass-to-charge ratio (m/z)
The quantity a mass spectrometer actually measures. Peptides often carry several charges, so one molecule can appear as multiple m/z peaks that must be deconvoluted back to a single molecular mass. Source: ICH Q6B
Chromatogram
The detector trace from an HPLC run: signal on the vertical axis, time on the horizontal axis. A credible purity claim is backed by the chromatogram itself, not just a number. Source: USP Pharmacopeial Discussion Group
Retention time
The time at which a component elutes from the column under a stated method. It depends on column, gradient, flow and temperature, so retention times are only comparable within the same method. Source: USP Pharmacopeial Discussion Group
Specificity
The ability of an analytical procedure to assess the analyte unequivocally in the presence of expected impurities, degradants or matrix components. A purity method without demonstrated specificity can hide co-eluting impurities. Source: ICH Q2(R2)
Limit of detection and limit of quantitation (LOD / LOQ)
LOD is the lowest amount of analyte a procedure can detect; LOQ is the lowest amount it can quantify with acceptable precision and accuracy. Impurities below the LOQ cannot be reported as numbers. Source: ICH Q2(R2)
Method validation
Documented evidence that an analytical procedure is fit for its intended purpose, covering characteristics such as specificity, accuracy, precision, range and robustness. Source: ICH Q2(R2)

Results and impurities

Area percent
Main-peak area divided by the total integrated peak area, expressed as a percentage. It is a relative measure of chromatographic purity at the detection wavelength, not a measure of how much peptide is in the vial. Source: USP Pharmacopeial Discussion Group · HPLC purity and area percent
Purity (chromatographic)
The share of detected material that is the target compound, usually reported by HPLC area percent. Research peptides are often reported above 95% by HPLC while the solid's net peptide content is lower because of counter-ions and water. Source: Bachem
Net peptide content
The fraction of a lyophilized solid's weight that is peptide, as opposed to counter-ions (acetate, TFA) and residual moisture. Bachem notes it is typically 70-90% even for high-purity material. Source: Bachem
Identity
Confirmation that the material is the stated molecule, typically by matching the observed mass (LC-MS or MALDI-TOF) to the theoretical mass of the sequence. Source: ICH Q6B
Molecular weight and monoisotopic mass
Molecular weight is the average mass using natural isotope abundance; monoisotopic mass uses the most abundant isotope of each element. PubChem lists both, and a mass-spec identity result should say which one it compares against. Source: PubChem documentation
Counter-ion
The ion paired with charged groups on a peptide in the solid salt form, most often trifluoroacetate or acetate. Counter-ions add weight, which is one reason net peptide content is below 100%. Source: Bachem
TFA salt
A peptide isolated with trifluoroacetate (PubChem CID 6422) as the counter-ion, a by-product of RP-HPLC purification. Cornish et al. (1999) reported residual TFA at 10^-8 to 10^-7 M reduced osteoblast proliferation in culture, so salt form matters for cell-based work. Source: Cornish J et al. Trifluoroacetate
Acetate salt
A peptide with acetate (from acetic acid, PubChem CID 176) as the counter-ion, usually produced by ion exchange after purification. Often specified when residual TFA could interfere with an assay. Source: PubChem CID 176
Deamidation
Chemical conversion of asparagine or glutamine side chains to acids, a common degradation pathway that shifts mass by about 1 Da and can show up as a new HPLC peak. Moisture and temperature accelerate it. Source: Manning MC et al. Stability of protein pharmaceuticals
Oxidation
Degradation of oxidation-prone residues, chiefly methionine, cysteine and tryptophan. Sigma-Aldrich recommends limiting air exposure (for example an inert-gas overlay) for sequences containing them. Source: Sigma-Aldrich (Merck)
Aggregation
Physical association of peptide or protein molecules into dimers or larger species. It is a physical (not chemical) instability and can be triggered by freeze-thaw stress, moisture or temperature excursions. Source: Manning MC et al. Stability of protein pharmaceuticals

Microbiology

Endotoxin
Lipopolysaccharide from the outer membrane of Gram-negative bacteria. Results are reported in endotoxin units (EU) against a reference standard. Source: FDA Guidance for Industry · Endotoxin testing (LAL)
Limulus amebocyte lysate test (LAL)
The compendial bacterial endotoxins test, using horseshoe-crab blood-cell lysate in gel-clot, turbidimetric or chromogenic formats. Recombinant factor C (rFC) reagents are a synthetic alternative that must be validated for the sample. Source: FDA Guidance for Industry
Sterility test
A culture-based test for viable microorganisms (USP <71>, harmonized through the PDG; 21 CFR 610.12 for licensed biologics). Sterility and endotoxin are different tests: a sterile sample can still contain endotoxin. Source: 21 CFR 610.12 · USP <71> sterility vs rapid methods

Documentation and quality systems

Certificate of analysis (COA)
A laboratory report of test results for a specific lot: methods, results, laboratory, report date and lot number. A COA is only as useful as its match to the lot in hand. Source: ICH Q2(R2) · Peptide COA checklist
Lot
A batch, or an identified portion of a batch, with uniform character and quality within specified limits (21 CFR 210.3). Test results apply to a lot, not to a product name. Source: 21 CFR 210.3
Lot number
The distinctive combination of letters, numbers or symbols from which the history of a batch or lot can be traced (21 CFR 210.3). It is the key that ties a vial label to its COA. Source: 21 CFR 210.3 · Verify a lot
Re-test period
The period during which a material is expected to remain within specification under defined storage conditions, after which it should be re-examined. ICH Q1A(R2) distinguishes it from the shelf life used for finished products. Source: ICH Q1A(R2)
ISO/IEC 17025
The international standard for the competence of testing and calibration laboratories. Accreditation is granted for a defined scope of methods, so check that the method on the COA is on the lab's scope. Source: ISO/IEC 17025 · ISO/IEC 17025 accreditation scope
Scope of accreditation
The published list of specific tests and methods an accredited lab is recognized to perform. Accreditation bodies that sign the ILAC MRA recognize each other's accreditations. Source: ILAC Mutual Recognition Arrangement and signatories
CAS Registry Number
A unique numeric identifier assigned by CAS to a chemical substance. Useful for unambiguous ordering and literature searches; it does not say anything about a specific lot's quality. Source: CAS Registry (CAS
PubChem CID
PubChem's compound identifier for a unique chemical structure, with computed properties such as formula and molecular weight. Different salt forms can have different CIDs. Source: PubChem documentation
Safety Data Sheet (SDS)
The standardized hazard document required under OSHA's Hazard Communication standard, covering hazards, handling, storage and exposure controls for a chemical. Source: OSHA 29 CFR 1910.1200
Research use only (RUO)
Labeling for materials sold for laboratory research. RUO materials are not intended for human or veterinary use, diagnostic use, or any use outside a controlled research setting. Source: OSHA 29 CFR 1910.1450

Handling and storage

Lyophilization
Freeze-drying: water is frozen and then removed by sublimation under vacuum, leaving a dry solid (the cake). The dry state slows most chemical degradation compared with solutions. Source: Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2) · Lyophilized material storage and handling
Hygroscopic
Readily absorbs moisture from air. Bachem notes most peptides are hygroscopic, and absorbed water reduces the peptide content of a weighed sample. Source: Bachem
Desiccator
A sealed container with a drying agent. Letting a cold vial warm to room temperature inside a desiccator before opening avoids condensation on the solid. Source: Bachem
Freezer (USP definition)
USP <659> defines a freezer as a place maintained thermostatically between -25 °C and -10 °C. Many peptide suppliers recommend -20 °C or colder for long-term storage of lyophilized material. Source: USP General Chapter <659> Packaging and Storage Requirements (Revision Bulletin)
Refrigerator (USP definition)
USP <659> defines refrigerated storage as a cold place maintained thermostatically between 2 °C and 8 °C. Source: USP General Chapter <659> Packaging and Storage Requirements (Revision Bulletin)
Controlled room temperature
USP <659>: thermostatically maintained 20-25 °C, with excursions between 15 °C and 30 °C allowed. Bachem notes lyophilized peptides generally tolerate room-temperature shipping. Source: USP General Chapter <659> Packaging and Storage Requirements (Revision Bulletin)
Dry place
USP <659>: a place that does not exceed 40% average relative humidity at 20 °C, or the equivalent water vapor pressure at other temperatures. Source: USP General Chapter <659> Packaging and Storage Requirements (Revision Bulletin)
Freeze-thaw cycle
One round of warming a frozen material and refreezing it. Repeated rounds add condensation and physical stress; Sigma-Aldrich recommends dividing material into single-use aliquots instead. Source: Sigma-Aldrich (Merck)
Aliquot
A measured portion split from a larger quantity so the rest stays sealed. Aliquoting limits repeated opening, moisture uptake and freeze-thaw exposure of the stock. Source: Sigma-Aldrich (Merck)
Photostability
Resistance to light-induced change. ICH Q1B confirmatory testing uses not less than 1.2 million lux hours of visible light plus 200 watt hours per square meter of near-UV, which is why amber or covered storage is the default. Source: ICH Q1B
Inert gas overlay
Replacing the air above a sample with dry nitrogen or argon before resealing. Recommended for sequences with oxidation-prone residues (Cys, Met, Trp). Source: Sigma-Aldrich (Merck)

How to use this glossary

Terms are grouped by where you meet them on a report. Every entry has a stable link (for example /glossary#area-percent) so lab notebooks, SOPs and other sites can cite a single definition.

Two distinctions cause most misreadings of a COA: chromatographic purity is not the same as net peptide content, and a purity result does not prove identity. The entries for area percent, net peptide content and identity explain why.

Frequently asked

Is HPLC purity the same as the amount of peptide in a vial?

No. HPLC area percent compares the main peak with other detected peaks. The solid also contains counter-ions and water, so net peptide content is typically lower (Bachem cites 70-90%).

What is the difference between a TFA salt and an acetate salt?

They differ in the counter-ion paired with the peptide. TFA comes from HPLC purification; acetate is usually introduced by ion exchange when residual TFA could interfere with cell-based assays.

What does a lot number prove?

Nothing on its own. It is the link between a vial label and the test record for that batch. Match it against the report or look it up on the supplier's lot verification page.

References

  1. USP Pharmacopeial Discussion Group: harmonized general methods (chromatography, endotoxins, sterility)Primary source for one or more definitions below.
  2. Cornish J et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999;277(5):E779-83. PMID 10567002Primary source for one or more definitions below.
  3. ICH Q6B, Specifications for Biotechnological/Biological ProductsPrimary source for one or more definitions below.
  4. ICH Q2(R2), Validation of Analytical ProceduresPrimary source for one or more definitions below.
  5. Bachem: Care and Handling of Peptides (net peptide content)Primary source for one or more definitions below.
  6. PubChem documentation: compounds, substances and CIDsPrimary source for one or more definitions below.
  7. PubChem CID 176: Acetic acidPrimary source for one or more definitions below.
  8. Manning MC et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-75. PMID 20143256Primary source for one or more definitions below.
  9. Sigma-Aldrich (Merck): Handling and Storage Guidelines for Peptides and ProteinsPrimary source for one or more definitions below.
  10. FDA Guidance for Industry: Pyrogen and Endotoxins Testing, Questions and AnswersPrimary source for one or more definitions below.
  11. 21 CFR 610.12, SterilityPrimary source for one or more definitions below.
  12. 21 CFR 210.3, Definitions (batch, lot, lot number)Primary source for one or more definitions below.
  13. ICH Q1A(R2), Stability Testing of New Drug Substances and ProductsPrimary source for one or more definitions below.
  14. ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratoriesPrimary source for one or more definitions below.
  15. ILAC Mutual Recognition Arrangement and signatoriesPrimary source for one or more definitions below.
  16. CAS Registry (CAS, a division of the American Chemical Society)Primary source for one or more definitions below.
  17. OSHA 29 CFR 1910.1200, Hazard Communication (Safety Data Sheets)Primary source for one or more definitions below.
  18. OSHA 29 CFR 1910.1450, Occupational exposure to hazardous chemicals in laboratoriesPrimary source for one or more definitions below.
  19. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. PMID 10967427Primary source for one or more definitions below.
  20. Bachem: Handling and Storage Guidelines for PeptidesPrimary source for one or more definitions below.
  21. USP General Chapter <659> Packaging and Storage Requirements (Revision Bulletin)Primary source for one or more definitions below.
  22. ICH Q1B, Photostability Testing of New Drug Substances and ProductsPrimary source for one or more definitions below.